Empowering the immune System against cancer

Safe and effective drugs against cancer

Lindis Biotech

The Trifunctional, Bispecific Onco-Immune Company
Lindis Biotech is a clinical stage bio-pharmaceutical company that is committed to the development of Triomab® antibodies – a new class of T-cell engaging bispecific antibodies, empowering the immune system to turn malignant cancers into manageable and possibly curable diseases.

Profile

We combine scientific & pharmaceutical experience. We engage for safe and efficacious biomedical products.

Science

Triomab® antibodies induce a highly potent immune response against the tumor. Read more about Triomab® here.

Partnering

We welcome license or co-develop opportunities for our proprietary Triomab® antibody platform. We bring our partners comprehensive expertise in bio-pharmaceutical production as well as clinical development know-how in Triomab® antibodies.

Publications & News

In the context of our collaborations, we have significantly contributed to numerous articles published in peer-reviewed journals.

Contact

Find our contact informations here.

Location

Lindis Biotech is located in the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried, Munich – one of the most vibrant biotech hot spots in Europe.